Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Cantor Fitzgerald
Daiichi Sankyo
Fuji
Johnson and Johnson
AstraZeneca
Baxter
Boehringer Ingelheim
Moodys

Generated: May 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019627

« Back to Dashboard

NDA 019627 describes DIPRIVAN, which is a drug marketed by Fresenius Kabi Usa and is included in one NDA. It is available from three suppliers. There is one patent protecting this drug. Additional details are available on the DIPRIVAN profile page.

The generic ingredient in DIPRIVAN is propofol. There are twelve drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the propofol profile page.
Summary for 019627
Tradename:DIPRIVAN
Applicant:Fresenius Kabi Usa
Ingredient:propofol
Patents:1
Formulation / Manufacturing:see details
Pharmacology for NDA: 019627
Physiological EffectGeneral Anesthesia
Medical Subject Heading (MeSH) Categories for 019627
Suppliers and Packaging for NDA: 019627
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DIPRIVAN propofol INJECTABLE;INJECTION 019627 NDA RX PHARMA-PACK, INC. 49836-023 N 49836-023-08
DIPRIVAN propofol INJECTABLE;INJECTION 019627 NDA RX PHARMA-PACK, INC. 49836-024 N 49836-024-10

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Oct 2, 1989TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10MG/ML
Approval Date:Jun 11, 1996TE:ABRLD:Yes
Patent:➤ Sign UpPatent Expiration:Jun 1, 2025Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 019627

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Fresenius Kabi Usa DIPRIVAN propofol INJECTABLE;INJECTION 019627-002 Jun 11, 1996 ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa DIPRIVAN propofol INJECTABLE;INJECTION 019627-002 Jun 11, 1996 ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa DIPRIVAN propofol INJECTABLE;INJECTION 019627-002 Jun 11, 1996 ➤ Sign Up ➤ Sign Up
Fresenius Kabi Usa DIPRIVAN propofol INJECTABLE;INJECTION 019627-002 Jun 11, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
McKesson
Healthtrust
McKinsey
Colorcon
Cipla
US Army
Johnson and Johnson
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.